The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

Blood. 2005 Jun 15;105(12):4894-5; author reply 4895. doi: 10.1182/blood-2004-12-4814.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Alleles
  • Gene Frequency
  • Genotype
  • Humans
  • Interleukin-10 / genetics*
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics*
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Polymorphism, Genetic*
  • Prognosis
  • Promoter Regions, Genetic*
  • Remission Induction
  • Time Factors
  • Treatment Outcome

Substances

  • Interleukin-10